Showing results (1491-1500 of 1,553) with videos related to

Sort By:
Pageof 156
European Journal of Cancer (Oxford, England : 1990)|January 26, 2024
Efficacy and safety of 'Second Adjuvant' therapy with BRAF/MEK inhibitors after local therapy for recurrent melanoma following adjuvant PD-1 based immunotherapyAmelia M Taylor, Janet McKeown, Florentia Dimitriou, et al.
Environmental Health Perspectives|June 25, 2020
Early-Life Environmental Exposures and Childhood Obesity: An Exposome-Wide ApproachMartine Vrijheid, Serena Fossati, Léa Maitre, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 16, 2007
Tradeoffs between income, biodiversity, and ecosystem functioning during tropical rainforest conversion and agroforestry intensificationIngolf Steffan-Dewenter, Michael Kessler, Jan Barkmann, et al.
Nature Medicine|February 5, 2008
Mouse models of rhinovirus-induced disease and exacerbation of allergic airway inflammationNathan W Bartlett, Ross P Walton, Michael R Edwards, et al.
Allergy|June 3, 2020
EAACI Biologicals Guidelines-Recommendations for severe asthmaIoana Agache, Cezmi A Akdis, Mubeccel Akdis, et al.
Environmental Research|May 6, 2019
Personal assessment of the external exposome during pregnancy and childhood in EuropeDavid Donaire-Gonzalez, Ariadna Curto, Antònia Valentín, et al.
Infection|September 17, 2013
Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)J Thoden, A Potthoff, J R Bogner, et al.
Allergy|March 3, 2021
COVID-19 pandemic and allergen immunotherapy-an EAACI surveyOliver Pfaar, Ioana Agache, Matteo Bonini, et al.
Allergy|February 9, 2020
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthmaIoana Agache, Jessica Beltran, Cezmi Akdis, et al.
Allergy|March 11, 2020
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthmaIoana Agache, Yang Song, Claudio Rocha, et al.
Pageof 156